These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7732591)

  • 61. Expression of cyclin-dependent kinase inhibitors in epiphyseal chondrocytes induced to terminally differentiate with thyroid hormone.
    Ballock RT; Zhou X; Mink LM; Chen DH; Mita BC; Stewart MC
    Endocrinology; 2000 Dec; 141(12):4552-7. PubMed ID: 11108267
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cell-cycle inhibitors: three families united by a common cause.
    Vidal A; Koff A
    Gene; 2000 Apr; 247(1-2):1-15. PubMed ID: 10773440
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cooperative alterations of Rb pathway regulators in mouse primary T cell lymphomas.
    Pérez de Castro IP; Malumbres M; Santos J; Pellicer A; Fernández-Piqueras J
    Carcinogenesis; 1999 Sep; 20(9):1675-82. PubMed ID: 10469610
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines.
    Fujishita T; Mizushima Y; Kashii T; Kobayashi M
    Anticancer Res; 1998; 18(3A):1537-42. PubMed ID: 9673367
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The fate of pancreatic tumor cell lines following p16 overexpression depends on the modulation of CDK2 activity.
    Calbó J; Serna C; Garriga J; Graña X; Mazo A
    Cell Death Differ; 2004 Oct; 11(10):1055-65. PubMed ID: 15309028
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Differential regulation of cyclin-dependent kinase inhibitors in monolayer and spheroid cultures of tumorigenic and nontumorigenic fibroblasts.
    LaRue KE; Bradbury EM; Freyer JP
    Cancer Res; 1998 Mar; 58(6):1305-14. PubMed ID: 9515820
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Expression of cell cycle regulator genes in KB, a human squamous cell carcinoma cell line, after irradiation.
    Uno M; Otsuki T; Hiratsuka J; Yoden E; Aihara T; Harada T; Imajo Y
    Int J Oncol; 2000 Nov; 17(5):947-54. PubMed ID: 11029497
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Increased expression of the P27KIP1 protein in human esophageal cancer cell lines that over-express cyclin D1.
    Doki Y; Imoto M; Han EK; Sgambato A; Weinstein IB
    Carcinogenesis; 1997 Jun; 18(6):1139-48. PubMed ID: 9214595
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE; Xiong Y
    Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Adenoviral transfer of cyclin-dependent kinase inhibitor genes suppresses collagen-induced arthritis in mice.
    Nasu K; Kohsaka H; Nonomura Y; Terada Y; Ito H; Hirokawa K; Miyasaka N
    J Immunol; 2000 Dec; 165(12):7246-52. PubMed ID: 11120858
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
    Iolascon A; Della Ragione F; Giordani L; Serra A; Saglio G; Faienza MF
    Haematologica; 1998 Sep; 83(9):771-7. PubMed ID: 9825572
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Lack of p19INK4d in human testicular germ-cell tumours contrasts with high expression during normal spermatogenesis.
    Bartkova J; Thullberg M; Rajpert-De Meyts E; Skakkebaek NE; Bartek J
    Oncogene; 2000 Aug; 19(36):4146-50. PubMed ID: 10962575
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Molecular cloning, expression pattern, and chromosomal localization of human CDKN2D/INK4d, an inhibitor of cyclin D-dependent kinases.
    Okuda T; Hirai H; Valentine VA; Shurtleff SA; Kidd VJ; Lahti JM; Sherr CJ; Downing JR
    Genomics; 1995 Oct; 29(3):623-30. PubMed ID: 8575754
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Physiological role of CDK inhibitors].
    Nakayama K
    Seikagaku; 2004 Sep; 76(9):1191-202. PubMed ID: 15524107
    [No Abstract]   [Full Text] [Related]  

  • 76. Alterations of pRb1-cyclin D1-cdk4/6-p16(INK4A) pathway in endometrial carcinogenesis.
    Semczuk A; Jakowicki JA
    Cancer Lett; 2004 Jan; 203(1):1-12. PubMed ID: 14670612
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mutational analysis of the p16 family cyclin-dependent kinase inhibitors p15INK4b and p18INK4c in tumor-derived cell lines and primary tumors.
    Zariwala M; Liu E; Xiong Y
    Oncogene; 1996 Jan; 12(2):451-5. PubMed ID: 8570224
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Role of the cyclin-dependent kinase inhibitor CDKN2A in familial melanoma.
    Hogg D; Brill H; Liu L; Monzon J; Summers A; From L; Lassam NJ
    J Cutan Med Surg; 1998 Jan; 2(3):172-9. PubMed ID: 9479083
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Deregulated expression of cell-cycle proteins during premalignant progression in SENCAR mouse skin.
    Rodriguez-Puebla ML; LaCava M; Gimenez-Conti IB; Johnson DG; Conti CJ
    Oncogene; 1998 Oct; 17(17):2251-8. PubMed ID: 9811455
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Identification of cell cycle-targeting microRNAs through genome-wide screens.
    Hydbring P; Wang Y; Bogorad RL; Yin H; Anderson DG; Li C; Sicinski P
    Cell Cycle; 2017; 16(23):2241-2248. PubMed ID: 29099267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.